Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
Date:11/7/2013

rsllc.com">david.schull@russopartnersllc.com
858.717.2310 Arena Pharmaceuticals, Inc.Condensed Consolidated Statements of Operations (In thousands, except per share data)Three months ended

September 30,Nine months ended
September 30,2013201220132012(unaudited)(unaudited)RevenuesNet product sales

$
2,011$$  3,330$Eisai collaborative revenue

97386468,93322,642Manufacturing services

4436032,1812,924Other collaborative revenue

1511843485  Total revenues

3,5781,48574,87825,651Operating Costs & ExpensesCost of product sales

46001,5140Cost of manufacturing services

6321.3963,2862,839Research & development

14,59211,61947,42840,165General & administrative

7,7607,39223,61418,963Amortization of acquired technology & other intangibles

01680517  Total operating costs & expenses

23,44420,57575,84262,484Interest & Other Income (Expense)Interest income

28416881Interest expense

(1,768)(1,804)(5,333)(7,324)Gain (Loss) from valuation of derivative liabilities

4,1005,25910,101(13,886)Loss on extinguishment of debt

000(6,338)Other

30673152103  Total interest & other income (expense), net

2,6663,5694,988(27,364)Net income (loss)

(17,200)(15,521)4,024(64,197)Deemed dividend related to beneficial conversion feature of convertible preferred stock

000(2,824)Net income (loss) allocable to common stockholders

$(17,200)$(15,521)$  4,024$(67,021)Net income (loss) per share allocable to common stockholders:Basic

$
(0.08)$
(0.07)$
.02$
(0.35)Diluted

$
(0.08)$
(0.07)$
.02$
(0.35)Shares used in calculating net income (loss) per share allocable to common stockholders:Basic

218,316213,881217,923189,545Diluted

218,316213,881224,354189,545Arena Pharmaceuticals, Inc.Condensed Consolidated Ba
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference
4. Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
5. Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
6. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1
7. Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
8. Former Semi-Pro Arena Football Player Bridged to Heart Transplant with the SynCardia Total Artificial Heart
9. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
10. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
11. Carena Launches 24/7 Virtual Care Delivery Service for Hospital Systems and Primary Care Clinics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 Apex Medical Corporation (Apex, TWSE: ... Area Care sectors, announces that it is appealing the judgment ... in Germany that found the headgear ... that it has initiated invalidity challenges against various ResMed patents ... counterattacking against trivial and junk patents. ResMed ...
(Date:7/29/2014)... MOUNTAIN VIEW, Calif. , July 29, 2014 ... antivirals has amplified with rising incidence rates and ... absence of a preventative vaccine. Change is underway ... and interferon regimens towards highly effective, easily-tolerated, interferon-free ... http://photos.prnewswire.com/prnh/20140728/130662 Gilead,s mega blockbuster ...
(Date:7/29/2014)... BEIJING , July 29, 2014 China ... "Company"), a leading fully integrated plasma-based biopharmaceutical company in ... Company plans to release second quarter 2014 financial results ... The Company,s management will hold a ... 6, 2014, which is 8:00 p.m., Beijing Time on ...
Breaking Medicine Technology:Apex Continues Fighting Against Patents to Free Up Competition 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4China Biologic to Report Second Quarter 2014 Financial Results 2China Biologic to Report Second Quarter 2014 Financial Results 3
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai 2WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai 3WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai 4WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai 5WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai 6Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 2Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 3Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 4Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 5Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 6Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 7Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 8Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 9Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 10Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 11Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 12Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 13Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 14Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 15Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 16Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 17Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 18
(Date:7/29/2014)... Gerontological Society of America (GSA) the nation,s ... has chosen Laura N. Gitlin, PhD, of the ... the 2014 recipient of the M. Powell Lawton Award. ... in gerontology that has led to an innovation in ... or barriers, or a public policy change that has ...
(Date:7/29/2014)... 2014 CD-adapco™, the largest privately ... software, today announced its renewed membership with ... public-private partnership focused exclusively on the unique needs ... progress in the first year by bringing together ... Computational Modeling and Simulation (CM&S). This momentum will ...
(Date:7/29/2014)... Biocides are chemical substances, which are able ... growth and to prevent degradation of the physical and ... surface. It is used in various applications such as ... paints and coatings. It is also used in domestic ... in industrial applications to prevent fouling in water and ...
(Date:7/29/2014)... the federal system for financing physician training and ... billion annual investment is producing the doctors that ... the Institute of Medicine. Current financing -- ... allocates funds independent of workforce needs or educational ... in the health care settings used by most ...
(Date:7/29/2014)... July 29, 2014 Frank Davis, Activz ... can help parents add nutrition to their kids’ meals ... – Key market drivers in kids’ foods market” by ... pleased to announce the interview Frank Davis had with ... Activz organic vegetable and fruit produce powders to kids ...
Breaking Medicine News(10 mins):Health News:Gitlin earns GSA's 2014 M. Powell Lawton Award 2Health News:CD-adapco Helps Advance the Use of Simulation in Medical Device Industry 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 4Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 2Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 3Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 2Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 3
... BIRMINGHAM, Ala. - New clinical data showed some cancer ... called AME-133v, said a researcher at the University of ... April 15th during the 2008 annual meeting of the ... Phase 1 clinical trial data showed AME-133v had a ...
... YORK, April 16 Jenni Schaefer, a young,woman ... with anorexia and,bulimia to become a well-known motivational ... girls everywhere, has been,appointed to the Ambassador Council ... a NEDA Ambassador, Schaefer will continue her travels ...
... April 16 Natural,Nutrition, Inc. (OTC Bulletin ... InterACTIVE Nutrition, Inc. (INII), http://www.interactivenutrition.com, achieved ... in EBITDA in the three month period ... exceeded the EBITDA requirements,for the company,s senior ...
... New NCPA,Study, DALLAS, April 16 The U.S. ... workers when they work,extra hours to get ahead, according ... Policy Analysis., "The impact on low-income workers and ... Kotlikoff, Boston University,professor and author of the study. "They ...
... are doomed to fail , , WEDNESDAY, April 16 (HealthDay ... household dust? Forget about it, a new study suggests. ... found that none was effective enough in reducing exposure ... The methods looked at included using chemicals to kill ...
... SAN DIEGO As potential cancer therapies proliferate, researchers ... to more accurately predict which patients will receive the ... Research 2008 Annual Meeting, April 12-16, 2008, researchers present ... cancer, how doctors can more effectively measure response to ...
Cached Medicine News:Health News:Jenni Schaefer, Motivational Speaker, Author Named National Eating Disorders Association (NEDA) Ambassador 2Health News:Natural Nutrition Subsidiary InterACTIVE Nutrition Reports First Quarter Revenue of $4,189,048 (CDN) and EBITDA of $504,500 (CDN) 2Health News:Tax Rates Mean Extra Work Doesn't Pay 2Health News:Dust Mites Trump Asthma Prevention Guidelines 2Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 2Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 3Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 4Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 5Health News:Measuring medicine: How new technologies could help doctors predict patient outcomes 6
The CGVL vitrectomy contact glass was designed by Rol, Fankhauser et al. for photodisruptive YAG laser procedures in the posterior vitreous....
For use with Slitlamps which have a smaller distance between the eye and the reduction prism than the Haag-Streit 900. Designed to work with argon/YAG Lasers....
Advanced Corneal Topography System with integrated Keratometer. Keratometric and topographic measurements all in one instrument....
The best combination with the Haag-Streit 900 Slitlamps. For examination of the entire fundus, the vitreous and the iridocorneal angle. For newly born children. 10 mm internal diameter of the cornea ...
Medicine Products: